Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults
Clinical trial NCT03039790 · COMPLETED
Trial details
- NCT number
- NCT03039790
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-21
- Primary completion
- 2021-07-22
- Enrollment
- 528
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.